COMPASS THERAPEUTICS, INC.
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, developing antibody therapeutics to treat both solid tumors and hematologic malignancies. Compass is leveraging its proprietary StitchMabsโข and common light-chain enabled multispecific platforms to empirically identify multispecifics and combinations of antibody therapeutics that can be advanced to the clinic. The company's lead product candidate, CTX-009, is a bispecific antibody, which inhibits both DLL4-mediated Notch... signaling and VEGF-A signaling. CTX-009 has completed a Phase 1 dose escalation study and is in a Phase 1b study in combination with chemotherapy in patients with solid tumors. The companyโs second product candidate, CTX-471, is a novel agonistic antibody of CD137, a co-stimulatory receptor on immune cells. It is currently being evaluated in a Phase 1b study in patients who were previously treated with PD-1/PD-L1 checkpoint inhibitors, and who subsequently relapsed or progressed after a period of stable disease. Compassโ third product candidate, CTX-8371, is a bispecific antibody that blocks both PD-1 and PD-L1 and is in IND-enabling studies. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
COMPASS THERAPEUTICS, INC.
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2014-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.compasstherapeutics.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
176.51 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Civitas Therapeutics
Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-05-13 | Trigr Therapeutics | Trigr Therapeutics acquired by Compass Therapeutics, Inc. | N/A |
Investors List
Montrose Capital Partners
Montrose Capital Partners investment in Venture Round - Compass Therapeutics, Inc.
Alexandria Venture Investments
Alexandria Venture Investments investment in Venture Round - Compass Therapeutics, Inc.
Biomatics Capital Partners
Biomatics Capital Partners investment in Venture Round - Compass Therapeutics, Inc.
F-Prime Capital
F-Prime Capital investment in Venture Round - Compass Therapeutics, Inc.
Borealis Ventures
Borealis Ventures investment in Venture Round - Compass Therapeutics, Inc.
Thiel Capital
Thiel Capital investment in Venture Round - Compass Therapeutics, Inc.
OrbiMed
OrbiMed investment in Venture Round - Compass Therapeutics, Inc.
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Venture Round - Compass Therapeutics, Inc.
F-Prime Capital
F-Prime Capital investment in Series A - Compass Therapeutics, Inc.
Thiel Capital
Thiel Capital investment in Series A - Compass Therapeutics, Inc.
Official Site Inspections
http://www.compasstherapeutics.com Semrush global rank: 1.92 M Semrush visits lastest month: 11.31 K
- Host name: 198.168.232.35.bc.googleusercontent.com
- IP address: 35.232.168.198
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York

More informations about "Compass Therapeutics, Inc."
Compass Therapeutics, Inc. - Crunchbase Company โฆ
Organization. Compass Therapeutics, Inc. Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. โฆSee details»
Pipeline - Compass Therapeutics
Nov 8, 2024 CTX-471 is an agonistic antibody directed against the co-stimulatory molecule CD137 (4-1BB). CD137, a member of the TNF receptor superfamily of proteins, provides a โฆSee details»
Compass Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Compass Therapeutics, Inc. of Brighton, MA. Get the latest business insights from Dun & Bradstreet.See details»
Compass Therapeutics - LifeScienceHistory.com
Www.compasstherapeutics.com. 80 Guest Street, Suite 601. Boston, MA 02135. Company Info Phone (617) 500-8099 Year Established 2013 Ticker CMPX Exchange NASDAQ. Contacts โฆSee details»
Compass Therapeutics - VentureRadar
"Compass Therapeutics is an antibody discovery and development company focused on comprehensively drugging the tumor-immune synapse with combinations of human โฆSee details»
News Release Details - Compass Therapeutics, Inc.
Apr 25, 2024 CTX-009, the Companyโs bispecific DLL4/VEGF-A antibody, in combination with paclitaxel, has shown promising clinical responses in patients with advanced biliary tract โฆSee details»
Compass Therapeutics - MassBio
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. โฆSee details»
Compass Therapeutics: Revenue, Worth, Valuation & Competitors โฆ
About Compass Therapeutics. Compass Therapeutics is a Biotech related company founded in 2014 and based in Cambridge with 42 employees an estimated revenue of $6M, and. It has 10 โฆSee details»
About โ Compass Therapeutics
Leadership Team. Our leadership team is recognized for their deep experience in drug discovery and development and their unwavering commitment to entrepreneurship and innovation.See details»
Compass Therapeutics - Montrose Capital Partners
Apr 14, 2025 URL: www.compasstherapeutics.com June 2020 APO Financing: $60,500,000 Trading Venue: NASDAQ CM (CMPX) Compass Therapeutics is a clinical-stage biopharmaceutical company developing proprietary antibody โฆSee details»
Home โ Compass Therapeutics, Inc.
Dec 4, 2024 Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases.See details»
Compass Therapeutics (CMPX) Company Profile & Description
Apr 14, 2025 Ticker Symbol: CMPX: Exchange: NASDAQ: Stock Type: Common Stock: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001738021: CUSIP โฆSee details»
Compass Therapeutics Inc. | LinkedIn
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases.See details»
Compass Therapeutics, Inc. (Compass Therapeutics, Inc.) - ่ฏ็ฉ็ฎก โฆ
The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at https://www.compasstherapeutics.com. โฆSee details»
Compass Therapeutics Announces $80 Million Private Placement
Nov 2, 2022 The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics, Inc. website at โฆSee details»
Compass Therapeutics Announces First Patient Dosed in an
1 day ago [email protected] 617-500-8099. Tags biliary tract cancer tovecimig clinical trial MD Anderson. Recommended Reading. April 02, 2025 16:05 ET | Source: โฆSee details»
CMPX - Compass Therapeutics, Inc. | Company Profile | OTC Markets
Mar 20, 2025 www.compasstherapeutics.com (617) 500-8099. [email protected]. Business Description. Compass Therapeutics, Inc. โฆSee details»
Compass Therapeutics to Participate in Upcoming Investor
Nov 13, 2024 [email protected]. Media Contact Anna Gifford, Senior Manager of Communications [email protected] 617-500-8099. Tags Conference ...See details»
Compass Therapeutics Provides Corporate Update and Announces ...
Jan 9, 2025 The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at โฆSee details»
Compass Therapeutics Doses First Patient in Investigator โฆ
1 day ago [email protected]. Media Contact Anna Gifford, Chief of Staff [email protected] 617-500-8099. This article was originally published on โฆSee details»